Testimonials from Doctors
It’s an excellent tool in cognitive assessment! I use the results to reassure patients, to prompt further testing, and to follow patients longitudinally.
—Dr. L. Algase, Partners in Internal Medicine
Cognivue’s impact on my practice has been tremendous! It helps with patient and family planning and treatment.
—Dr. R. Constantino, RRHS
It improved my ability to work with dementia patients and their CGs…I especially like the graphics.
—Dr. R. Mittereder, Unity Geriatrics
[Cognivue] helped me sort out who has cognitive problems or not.
—Dr. L. Rice, RRHS
Cognivue has been a great addition!!!! Far better than the MMSE...I say it is a cognitive CBC or EKG and patients are educated in a way we couldn't do before....and so am I!!
—Dr. C. Stringer, CNY Internists PC
Interpreting Cognivue® One-Page Test Results
Clinical Testing Context
Three factors provide important context for evaluating Cognivue scores. All test scores should be considered in the context of:
- Clinical correlation with the patient’s medical conditions and medical history.
- Previous Cognivue test results, or related testing that may indicate the level of baseline function.
- New diagnoses that might explain declines in function and aid in planning for further diagnostic testing.
Discussing Test Results with Patients
Cognivue testing provides an adjunctive tool for assessing brain functional capacities. Test reports showing good performance, evidence of impairment, and functional decline will require different discussions and follow-up. Refer to page 21 of the Cognivue Practitioner’s Training Manual for discussion recommendations.
Cognivue’s Clinical Use Protocol
- Candidates are 55 to 95 years of age—with patient, caregiver, or practitioner concerns regarding impairment.
- Testing is under supervision of a licensed practitioner
- the staff administers test, and the practitioner interprets the report.
- Cognivue is an adjunctive test, so clinical correlation is required
- Cognivue is a reimbursable, FDA-approved cognitive test.
Why is it Important to Detect Early Impairment?
- Treat reversible dementias (specific treatments)
- Ameliorate irreversible dementias (nootropics and psychotropics)
- Facilitate contextual care (managing co-morbidities)
- Support the patient (drive adaptations and manage expectations)
- Avoid complications (reduce risk of polypharmacy, unnecessary diagnostics, and referrals)
- Support caregivers (encourage planning and accommodations)
Common, Treatable Causes of Impairment
Common causes of reversible impairment include sleep disorders, infection, systemic illness, and mood disorders.
For more information on types of reversible dementia, please review the Cerebral Assessment Systems White Paper, “Causes of Dementia.”
Metabolic and Systemic Issues Related to Impairment
- Endocrine disorders: e.g., hypothyroidism
- Deficiencies: e.g., B vitamins
- Organ failure: e.g., hepatic, renal, cardiac
- Inflammatory: e.g., temporal arteritis (GCA)
- Infectious: e.g., UTIs, URIs, HIV
Assisting Patients with Neurodegenerative Impairment
- Patients with neurodegenerative impairment benefit from the judicious use of nootropic or psychotropic medication, support in adjustment, and guided accommodations
- For more information on why we must help patients with neurodegenerative impairment, please review CAS- Consequences of Dementia- The risks older adults with dementia pose to themselves, others, and society
How Can Primary Care Testing Influence Brain Health Outcomes?
- Automated, objective multi-domain measures
- Practitioner interpretation in context of presentation
- Limit work-up in unimpaired patients
- Focus work-up in impaired patients
- Reassure unimpaired patients and their families to limit further work-up and unnecessary referrals
- Engage impaired patients and caregivers in planning and arranging support services
The Science of Psychophysical Profiles
See CME 1: “The Origins of Cognivue Technology” for more on the science of psychophysical profiles.
Sample screens for Visuo-Motor Calibration
Contact us today for Continuing Medical Education (CME) presentations.